Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FEVERTREE DRINKS PLC Regulatory Filings 2022

Mar 18, 2022

7637_div_2022-03-18_87f5fd85-108f-49b2-a72f-7854a8e95e74.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2092F

Fevertree Drinks PLC

18 March 2022

Fevertree Drinks Plc

Correction to Dividend Shareholder Register Date Declaration

On 16 March 2022, Fevertree Drinks plc announced, in conjunction with its preliminary results, a proposed final and special dividend for 2022 subject to the approval of shareholders at the AGM to be held on 19 May 2022.

The date regarding the shareholder register for this proposed final and special dividend was incorrect and should have read: "If approved by shareholders at the AGM on 19 May 2022 the final and special dividends will be paid on 27 May 2022 to shareholders on the register on 8 April 2022."

All other details set out in the announcement were correct and remain unchanged.

For more information please contact:

Investor queries

Ann Hyams, Director of Investor Relations I [email protected] I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I [email protected] I +44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUQCWUPPPUM